"Pratia Warszawa to doświadczony ośrodek badań klinicznych. Pratia powstała w trosce o pacjentów, którzy zmagają się z chorobami przewlekłymi i chcą uzyskać dostęp do nowoczesnych metod leczenia, które są w fazie badań klinicznych. Prowadzimy badania w ponad 20 obszarach terapeutycznych między innymi w dermatologi, diabetologi, gastroenterologi, ginekologi, laryngologi, immunologi, kardiologi, neurologi, nefrologi, onkologi, ortopedia pediatrii, pulmonologi, reumatologi, a także badania dotyczące szczepionek. Badania kliniczne proponowane naszym pacjentom uzyskały zgodę Ministerstwa Zdrowia oraz mają pozytywną opinię niezależnej Komisji Bioetycznej."

During the past decade, Centrum Medyczne Pratia Warszawa conducted 26 clinical trials. In the 10-year time frame, 26 clinical trials started and 10 clinical trials were completed, i.e. on average, 38.5% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 10 clinical trials were completed. i.e. 125% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centrum Medyczne Pratia Warszawa" #1 sponsor was "Shire" with 4 trials, followed by "Amgen" with 2 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored, "Intec Pharma Ltd." with 2 trials sponsored and "Janssen Research & Development, LLC" with 2 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centrum Medyczne Pratia Warszawa" #1 collaborator was "Syneos Health" with 2 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Medpace, Inc." with 1 trials as a collaborator and "TFS Trial Form Support" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Centrum Medyczne Pratia Warszawa" are "Crohn's Disease" (3 trials), "Ulcerative Colitis" (3 trials), "Alzheimer Disease" (2 trials), "Cervical Dystonia" (2 trials) and "Parkinson's Disease" (2 trials). Many other conditions were trialed in "Centrum Medyczne Pratia Warszawa" in a lesser frequency.

Most popular intervention types in "Centrum Medyczne Pratia Warszawa" are "Drug" (21 trials), "Biological" (5 trials) and "Other" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (14 trials), "Ontamalimab" (3 trials), "Accordion Pill™ Carbidopa/Levodopa" (2 trials), "Gantenerumab" (2 trials) and "Nabiximols" (2 trials). Other intervention names were less common.

The vast majority of trials in "Centrum Medyczne Pratia Warszawa" are 26 trials for "All" genders.

Currently, there are NaN active trials in "Centrum Medyczne Pratia Warszawa". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 9 completed trials in Centrum Medyczne Pratia Warszawa, undefined suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in Centrum Medyczne Pratia Warszawa, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 1 trials that are defined as “Not Applicable".